Type 2 Diabetes Archives - Renal and Urology News

Some evidence suggests that cannabis smoking may increase the risk of heart attack, however more evidence is needed to substantiate the claim; evidence on how cannabis impacts stroke and diabetes risk is also limited.

AHA Releases Scientific Statement on Management of Cardiovascular Risk Factors in Type 2 Diabetes

By

Sheila Jacobs

February 10, 2022

The AHA released a statement focusing on the importance of managing cardiovascular risk factors in patients with type 2 diabetes.

Diabetic Nephropathy

Cardiac Events With Type 2 Diabetes, Kidney Disease Reduced With Finerenone

By

Jessica Nye, PhD

October 25, 2021

Chronic kidney disease increases the risk of cardiovascular events associated with type 2 diabetes. A clinical trial sought to discover if finerenone would help patients with both of these conditions.

Diabetes

SGLT2 Inhibitors Lead to Favorable Renal, CV Outcomes in Type 2 Diabetes

By

Brandon May

September 7, 2021

Using certain glucose inhibitors in people with type 2 diabetes may also have a beneficial effect on renal and cardiovascular health, and weight.

Diabetes

ADA: Tirzepatide Noninferior, Superior to Semaglutide for T2DM

July 2, 2021

Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes

Diabetes

Suboptimal Use of SGLT2 Inhibitors in Individuals With Diabetes and Heart Failure

By

Endocrinology Advisor Contributing Writer

June 17, 2021

A team of investigators assessed the frequency with which patients with type 2 diabetes and heart failure were prescribed sodium-glucose co-transporter 2 inhibitors.

Diabetes

HbA1c May Predict Outcome in Patients With Type 2 Diabetes Admitted for Acute Stroke

By

Endocrinology Advisor Contributing Writer

June 16, 2021

A team of investigators sought to identify the impact of hyperglycemia on the severity of and outcomes associated with stroke in patients with type 2 diabetes.

Diabetes

Older Age, Diabetes Duration, and CAD Are Leading Risk Factors for PAD in Patients With T2DM

By

Colby Stong

June 15, 2021

Researchers report the results of a systematic review assessing risk factors for peripheral artery disease in populations with type 2 diabetes.

News

Ertugliflozin Plus Insulin Improves Body Weight, HbA1c, and More for T2DM

By

Endocrinology Advisor Contributing Writer

April 28, 2021

Researchers sought to determine whether ertugliflozin plus insulin would help redice body weight, systolic blood pressure, HbA1c, and other metrics among individuals with T2DM.

Diabetes

Patients With Diabetes and CVD on Empagliflozin Have Fewer CV, Renal Events

By

Jessica Nye, PhD

November 5, 2020

Researchers assessed the risk for obstructive sleep apnea (OSA) among patients with type 2 diabetes and cardiovascular disease taking empagliflozin and further examined the effect of OSA on metabolic, cardiovascular, and renal outcomes.